Onglyza® Side Effects Include an Increased Risk for Heart Attack and Pancreatic Cancer

Onglyza® is a dipeptidyl peptidase-4 (DPP-4) inhibitor that has been linked to an increased risk of pancreatitis, pancreatic cancer, and heart failure. If you or a loved one is suffering from ONGLYZA® side effects, our San Diego, CA, attorneys can help build an effective legal case to seek compensation. As more patients and doctors become aware of the risks associated with this medication, the number of lawsuits filed against the manufacturer is expected to grow. Our lawyers have over 30 years of experience in personal injury law, and they are renowned for their expertise in pharmaceutical drug cases. They can tirelessly fight to help you seek the compensation you deserve to cover medical bills, as well as pain and suffering. To learn more about the dangers of ONGLYZA® and to find out if you qualify for the lawsuit, contact our firm today.

Man suffering heart attack
Patients taking ONGLYZA® were 27 percent more likely to be hospitalized for heart failure than those not taking this drug.

SIDE EFFECTS AND SERIOUS RISKS OF ONGLYZA®

ONGLYZA® is a common drug for Type 2 diabetes in adults. The most frequent risks of ONGLYZA® include issues such as headaches, infection, swelling, problems swallowing or breathing, skin issues, joint pain, and low blood sugar. While the more commonly documented side effects of this drug can be serious, they are rarely life-threatening.

Recent lawsuits stem from fatal side effects, including heart failure.One study analyzed 16,492 patients taking ONGLYZA®. Of those individuals, 1,222 reported serious heart complications. The study concluded that patients taking this drug were 27 percent more likely to be hospitalized for heart failure than those not taking ONGLYZA®. As a result, in 2015, the FDA required ONGLYZA® to place a warning label on the box regarding the potential heart complications. One member of the FDA panel voted to take the drug off of the market altogether.

Onglyza® and Pancreatitis

In addition to the cardiovascular complications, ONGLYZA® can also increase your risk for pancreatitis. In some cases, inflammation of the pancreas can even be fatal. A 2013 study showed that patients taking ONGLYZA® and other DPP-4 inhibitors had pancreases that were 40 percent larger than patients taking alternative diabetes medications. Pancreatitis is also a leading cause of pancreatic cancer, which diabetic patients are already at a higher risk to develop. 

Our lawyers are widely recognized for their proven track record with defective drug claims. They can fight tirelessly for your just compensation while providing compassionate personal assistance.

Are You Suffering from Onglyza® Side Effects?

If you or a loved one has suffered heart failure, pancreatitis, or pancreatic cancer as a result of ONGLYZA®, you may benefit from pursuing a lawsuit against its manufacturer. Most of the claims have been consolidated into a multidistrict litigation (MDL). In this way, the courts can issue widespread rulings against the manufactures of ONGLYZA®. At the same time, individual plaintiffs can receive personalized settlements for their claims. These types of cases can be very complex. Therefore, it is important to work with an experienced attorney. Our lawyers are widely recognized for their proven track record with defective drug claims. They can fight tirelessly for your just compensation while providing compassionate personal assistance.

Discover Your Legal Options

If you are suffering from the effects of ONGLYZA®, contact our firm for a no-cost consultation. We can help you understand your legal options to help you recover and face the future.